PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-1.37%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
9.90%
Cost growth 50-75% of CRWV's 19.16%. Bruce Berkowitz would examine sustainable cost advantages.
-4.14%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
-2.81%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
-7.19%
R&D reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine competitive risk.
-47.03%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
-12.59%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
-14.25%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-7.40%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-5.14%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
16.73%
EBITDA growth 50-75% of CRWV's 33.05%. Martin Whitman would scrutinize operations.
15.66%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
12.42%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
13.97%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
82.58%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
15.04%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
16.63%
Pre-tax margin growth 50-75% of CRWV's 26.86%. Martin Whitman would scrutinize operations.
8.57%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
17.37%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
19.00%
Similar net margin growth to CRWV's 25.27%. Walter Schloss would investigate industry trends.
17.65%
Similar EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
17.65%
Similar diluted EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
0.16%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
0.26%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.